MedTrace Logo

Impulse Oscillometry for Prognostication in Idiopathic Pulmonary Fibrosis

NCT03898284 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2021-11-11

No results posted yet for this study

Summary

A 5-point decline of forced vital capacity expressed as % predicted, over 6 months, is the current definition of disease progression (fast decline in lung function) in idiopathic pulmonary fibrosis. There is a need for techniques allowing to characterize disease progression earlier, so that treatment may be adapted as early as possible in the lack of a response.

Hypothesis. Our hypothesis is that 3-month changes of lung function parameters measured by a novel technique, impulse oscillometry, predicts 6-month changes in forced vital capacity in idiopathic pulmonary fibrosis.

Conditions

Interventions

DIAGNOSTIC_TEST

Impulse Oscillometry

Impulse Oscillometry will be performed in addition to usual care

Sponsors & Collaborators

  • University Hospital, Tours

    lead OTHER

Principal Investigators

  • Laurent PLANTIER, MD-PhD · University Hospital, Tours

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-23
Primary Completion
2021-09-27
Completion
2021-09-27

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03898284 on ClinicalTrials.gov